Benign prostatic hyperplasia (BPH), also known as an enlarged prostate, is a common condition that may affect your quality of life. Interrupted sleep and frequent bathroom visits can be disruptive and inconvenient at best. If you’d prefer a minimally invasive treatment for frequency or trouble with urine stream and/or urination, talk to your doctor about the iTind procedure.
1. Urology Care Foundation, Benign Prostatic Hyperplasia. September 2023. https://www.urologyhealth.org/educational-resources/benign-prostatic-hyperplasia-(bph)
Minimally Invasive BPH Treatment
with the iTind Procedure
The iTind procedure is the least invasive alternative to daily BPH pills, offering a rapid, effective and durable treatment of enlarged prostate that preserves sexual function and urinary continence.2,3
2. Amparore D, Fiori C, Valerio M, et al. 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2021.
3. Chughtai B, Elterman D, Shore N, et al. The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial. Urology. 2021.
Why Choose the iTind Procedure?
The iTind procedure is a new alternative to prescription medication or invasive surgery.
Key Benefits
Rapid symptom relief2,3,4
Preserves sexual and ejaculatory function3,4
Temporary implant removed after 5 to 7 days
Low post-op catheterization
Typically you go home without a catheter after the implant procedure as well as the removal procedure. In rare cases, acute urinary retention may occur, requiring insertion of a catheter.2
Clinical studies show symptomatic relief for at least 4 years.5
2. Amparore D, Fiori C, Valerio M, et al. 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2021.
3. Chughtai B, Elterman D, Shore N, et al. The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial. Urology. 2021.
4. De Nunzio C, Cantiello F, Fiori C, et al. Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study. World J Urol. 2021.
5. Amparore D, De Cillis S, Schulman C, Kadner G, Fiori C, Porpiglia F. Temporary implantable nitinol device for benign prostatic hyperplasia-related lower urinary tract symptoms: over 48-month results. Minerva Urol Nephrol. 2023 Jun 23. doi: 10.23736/S2724-6051.23.05322-3. Epub ahead of print. PMID: 37350585.
Ask your doctor about the iTind procedure if you do not want to take a pill every day, or if you have tried standard drug treatments and did not have the reduction in symptoms you wanted or you are unhappy with the way they made you feel.
As with any medical procedure, individual results vary. Men with moderate to severe BPH symptoms are generally good candidates for the procedure. Speak with your doctor to see if the iTind procedure is right for you.
What are the risks?
The iTind procedure is a safe and effective treatment for BPH in men age 50 and older. Some patients experience side effects during the procedure, but they are generally only mild to moderate. Side effects, if experienced, include pain or burning with urination, blood in the urine, pelvic pain, an urgent need to urinate and/or the inability to control the urge. Most of these side effects occur during the 5 to 7 day treatment period and resolve shortly after the device is removed.
